Meeting
2015 ASCO Annual Meeting
A single arm, single stage phase II trial of trametinib (GSK1120212) and GSK2141795 in persistent or recurrent cervical cancer.
Authors
Ursula Matulonis
Dana-Farber Cancer Inst, Boston, MA
Ursula Matulonis , Alexi A. Wright , Siobhan A Collins , Susana M. Campos , Panagiotis Konstantinopoulos , Kimberley MacNeill , Victoria Patterson , Christin Whalen , Joyce Liu , Stephanie Morrissey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Other Gynecologic Cancer
Clinical Trial Registration Number
NCT01958112
Citation
J Clin Oncol 33, 2015 (suppl; abstr TPS5618)
DOI
10.1200/jco.2015.33.15_suppl.tps5618
Abstract #
TPS5618
Poster Bd #
169b
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Adding targeted inhibition of PI3K and MAPK signaling pathways to standard chemotherapy in experimental pancreatic cancer.
First Author: Niranjan Awasthi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Tumor genomics and sidedness to predict outcomes in metastatic colorectal cancer (mCRC).
First Author: Patrick M Boland
Poster
2023 ASCO Annual Meeting
The efficacy and safety of tislelizumab plus bevacizumab and chemotherapy as first line therapy in patients with persistent, recurrent, or metastatic cervical cancer: A multicenter, phase II study.
First Author: Jianqing Zhu
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel